Thomas Woiwode

Thomas Woiwode, Ph.D., has served as a member of the board of directors since the company’s inception in 2018. Since 2002, Dr. Woiwode has served in various investment and operational roles at Versant Venture Management, LLC, including Managing Director since July 2014 and a Venture Partner from 2011 to 2014. From 2011 to 2013, Dr. Woiwode served as Chief Operating Officer of Okarios AG, a biopharmaceutical company. Previously, Dr. Woiwode co-founded EuroVentures, a wholly owned biotechnology incubator within Versant, and in this role, served as the founding Chief Business Officer for three biotechnology portfolio companies. Prior to Versant, Dr. Woiwode served as a Research Scientist at XenoPort, Inc.. Dr. Woiwode currently serves on the boards of directors of Adverum Biotechnologies, Inc., Aligos Therapeutics, Inc., Gritstone Oncology, Inc. and Passage Bio, Inc., as well as several private companies. Dr. Woiwode previously served on the board of directors of Audentes Therapeutics, Inc. and Crispr Therapeutics AG. Dr. Woiwode received a B.A. in English and a B.S. in Chemistry from the University of California, Berkeley and a Ph.D. in Organic Chemistry as an NSF Fellow from Stanford University